Welcome to LookChem.com Sign In|Join Free
  • or
4-Butoxyzacetanilide, also known as 4-butoxyacetanilide, is an organic compound with the chemical formula C11H15NO2. It is a derivative of acetanilide, where a butoxy group (C4H9O) replaces one of the hydrogen atoms on the nitrogen atom. 4-BUTOXYACETANILIDE is primarily used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, particularly in the production of herbicides and other chemical products. 4-Butoxyzacetanilide is a colorless to pale yellow solid, and its properties include low solubility in water and high solubility in organic solvents. It is important to handle this chemical with care due to its potential toxicity and environmental impact.

2109-73-1

Post Buying Request

2109-73-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2109-73-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2109-73-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,0 and 9 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 2109-73:
(6*2)+(5*1)+(4*0)+(3*9)+(2*7)+(1*3)=61
61 % 10 = 1
So 2109-73-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO2/c1-9(14)13-10-5-7-11(8-6-10)15-12(2,3)4/h5-8H,1-4H3,(H,13,14)

2109-73-1Downstream Products

2109-73-1Relevant academic research and scientific papers

Design, synthesis and biological testing of a novel series of anti-inflammatory drugs

Duffy,Dearden,Rostron

, p. 1505 - 1514 (2007/10/03)

Many of the non-steroidal anti-inflammatory drugs (NSAIDs) currently marketed produce severe gastro-toxic side effects. The benefits of producing NSAIDs without these side effects are obvious, particularly for patients requiring long-term therapy. The aim of this investigation was to produce novel NSAIDs, based on paracetamol, that exhibit little or no gastro-toxicity. The work covers design, synthesis and testing of 13 drug candidates. The analgesic and anti-inflammatory potencies of the drug candidates were measured using the mouse abdominal constriction assay and the carrageenan-induced rat paw oedema assay, respectively. The stomachs of the rats were examined post-mortem, to assess the gastro-toxicity of the drugs. Of the 13 compounds described herein, 11 were shown to possess analgesic activity at 2-10 times the potency of aspirin, while 8 demonstrated anti-inflammatory activity at 3-10 times the potency of aspirin. Significantly, all of the compounds showed very low gastro-toxicity when compared with aspirin. The results of this study indicate that it is possible to develop novel, potent NSAIDs based on the structure of paracetamol. These compounds have the advantage of demonstrating much lower gastro-toxicity than NSAIDs currently available. Drugs of this type may, in future, provide effective treatments for inflammatory disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2109-73-1